This preliminary study represents the first approach in the field of feline oncology, and the observation of a high p62 immunohistochemical expression in feline mammary carcinomas represents the first basis for considering p62 as a possible oncological target. This evidence concerns the gene SQSTM1 and breast carcinoma.